Pfizer and BioNTech Publish Results of Study Showing COVID-19 Vaccine Elicits Antibodies that Neutralize Pseudovirus Bearing the SARS-CoV-2 U.K. Strain Spike Protein in Cell Culture Read more about Pfizer and BioNTech Publish Results of Study Showing COVID-19 Vaccine Elicits Antibodies that Neutralize Pseudovirus Bearing the SARS-CoV-2 U.K. Strain Spike Protein in Cell Culture
Statement on European Upscaling as well as Impact on Deliveries Read more about Statement on European Upscaling as well as Impact on Deliveries
Statement on Voluntary COVID-19 Vaccination for BioNTech Employees and Suppliers to Ensure Undisrupted Manufacturing and Distribution of COVID-19 Vaccine Doses Read more about Statement on Voluntary COVID-19 Vaccination for BioNTech Employees and Suppliers to Ensure Undisrupted Manufacturing and Distribution of COVID-19 Vaccine Doses
JP Morgan Healthcare Conference Presentation 2021.01.11 Read more about JP Morgan Healthcare Conference Presentation 2021.01.11
Statement regarding European Commission’s Proposal to Purchase Additional Doses of BioNTech-Pfizer Vaccine Read more about Statement regarding European Commission’s Proposal to Purchase Additional Doses of BioNTech-Pfizer Vaccine
An In Vitro Study Shows Pfizer-BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with a Mutation Associated with Rapid Transmission Read more about An In Vitro Study Shows Pfizer-BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with a Mutation Associated with Rapid Transmission
BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science Read more about BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science
BioNTech to Present at the 39th Annual J.P. Morgan Healthcare Conference Read more about BioNTech to Present at the 39th Annual J.P. Morgan Healthcare Conference
BioNTech Recognizes Employees and Partners for Their Support in Developing Historic Vaccine Read more about BioNTech Recognizes Employees and Partners for Their Support in Developing Historic Vaccine
Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY® Read more about Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®
